Gilead Sciences, Inc.(NASDAQ:GILD) and Galapagos NV (NASDAQ:GLPG) announced that the U.
Gilead Sciences, Inc. (NASDAQ:GILD) announced that it has submitted a New Drug Application (NDA) to the U.
The 34th Annual JP Morgan Healthcare Conference kicked off today with several life science tools and diagnostic firms making presentations to investors and other attendees. Among …
To kick off biotech in 2016, analyst Joshua Schimmer of Piper Jaffray pounds the table on both Gilead Sciences, Inc. (NASDAQ:GILD) and Amgen, …
Analysts are not wasting a minute in 2016 as they are already eager to weigh in on two of the most popular stocks, Apple …
Apple Inc. (NASDAQ:AAPL), Alibaba Group Holding Ltd (ADR) (NYSE:BABA), and Gilead Sciences, Inc.
After two consecutive winning days, the major indexes suffered losses on Thursday, with the iShares Nasdaq Biotechnology Index losing 1.14%.
Galapagos NV (ADR) (NASDAQ:GLPG) and Gilead Sciences, Inc. (NASDAQ:GILD) announced that the companies have entered into a global partnership for the development and …
Gilead Sciences, Inc. (NASDAQ:GILD) announced that its Marketing Authorization Application (MAA) for an investigational, once-daily fixed-dose combination of the nucleotide analog polymerase inhibitor …
Piper Jaffray’s healthcare analyst Joshua Schimmer came out today with a few insights on the pharmaceutical giant Gilead Sciences, Inc. (NASDAQ:GILD) and clinical-stage biotechnology company bluebird bio …
